Terms: = Breast cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
44 results:
1. Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening.
Nakadai T; Yang L; Kumegawa K; Maruyama R
Mol Biol Rep; 2023 Feb; 50(2):1209-1220. PubMed ID: 36436079
[TBL] [Abstract] [Full Text] [Related]
2. An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the breast.
Vranic S; Gatalica Z
Clin Breast Cancer; 2022 Jun; 22(4):e576-e585. PubMed ID: 35027319
[TBL] [Abstract] [Full Text] [Related]
3. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review.
Chang B; Bai Q; Liang L; Ge H; Yao Q
Diagn Pathol; 2020 Sep; 15(1):110. PubMed ID: 32921307
[TBL] [Abstract] [Full Text] [Related]
4. System-level responses to cisplatin in pro-apoptotic stages of breast cancer MCF-7 cell line.
Fallahi H; Godini R
Comput Biol Chem; 2019 Dec; 83():107155. PubMed ID: 31706153
[TBL] [Abstract] [Full Text] [Related]
5. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract] [Full Text] [Related]
6. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
[TBL] [Abstract] [Full Text] [Related]
7. Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing.
De Mattos-Arruda L; Bidard FC; Won HH; Cortes J; Ng CK; Peg V; Nuciforo P; Jungbluth AA; Weigelt B; Berger MF; Seoane J; Reis-Filho JS
Mol Oncol; 2014 Feb; 8(1):150-8. PubMed ID: 24220311
[TBL] [Abstract] [Full Text] [Related]
8. PELP1: a review of PELP1 interactions, signaling, and biology.
Girard BJ; Daniel AR; Lange CA; Ostrander JH
Mol Cell Endocrinol; 2014 Jan; 382(1):642-651. PubMed ID: 23933151
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear EGFR as a molecular target in cancer.
Brand TM; Iida M; Luthar N; Starr MM; Huppert EJ; Wheeler DL
Radiother Oncol; 2013 Sep; 108(3):370-7. PubMed ID: 23830194
[TBL] [Abstract] [Full Text] [Related]
10. Diastereotopic and deuterium effects in gemini.
Maehr H; Rochel N; Lee HJ; Suh N; Uskokovic MR
J Med Chem; 2013 May; 56(10):3878-88. PubMed ID: 23566225
[TBL] [Abstract] [Full Text] [Related]
11. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
[TBL] [Abstract] [Full Text] [Related]
12. Anti-estrogenic activity of a human resveratrol metabolite.
Ruotolo R; Calani L; Fietta E; Brighenti F; Crozier A; Meda C; Maggi A; Ottonello S; Del Rio D
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1086-92. PubMed ID: 23465317
[TBL] [Abstract] [Full Text] [Related]
13. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
Moi LL; Flågeng MH; Gjerde J; Madsen A; Røst TH; Gudbrandsen OA; Lien EA; Mellgren G
BMC Cancer; 2012 Jun; 12():247. PubMed ID: 22703232
[TBL] [Abstract] [Full Text] [Related]
14. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
[TBL] [Abstract] [Full Text] [Related]
15. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract] [Full Text] [Related]
16. Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.
Tzelepi V; Grivas P; Kefalopoulou Z; Kalofonos H; Varakis JN; Melachrinou M; Sotiropoulou-Bonikou G
Virchows Arch; 2009 Apr; 454(4):389-99. PubMed ID: 19277704
[TBL] [Abstract] [Full Text] [Related]
17. Estrogen receptor alpha/beta, AIB1, and tif2 in colorectal carcinogenesis: do coregulators have prognostic significance?
Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
Int J Colorectal Dis; 2009 Jun; 24(6):613-22. PubMed ID: 19198856
[TBL] [Abstract] [Full Text] [Related]
18. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract] [Full Text] [Related]
19. The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer.
Hsia EY; Zou JX; Chen HW
Prog Mol Biol Transl Sci; 2009; 87():261-98. PubMed ID: 20374707
[TBL] [Abstract] [Full Text] [Related]
20. Steroid receptor coactivator 2: an essential coregulator of progestin-induced uterine and mammary morphogenesis.
Mukherjee A; Amato P; Craig-Allred D; DeMayo FJ; O'Malley BW; Lydon JP
Ernst Schering Found Symp Proc; 2007; (1):55-76. PubMed ID: 18540568
[TBL] [Abstract] [Full Text] [Related]
[Next]
